Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended Jun...(nd minority interest ...),Health
nd minority
interest (4,634) 128,797 (459,956) 110,469
Income tax (benefit)
provision (30,955) 49,207 (75,060) 101,957
Earnings (loss) before
minority interest 26,321 79,590 (384,896) 8,512
Minority interest (income)
expense (72) (137) (2,114) 74
Net earnings (loss)
before preferred
dividends 26,393 79,727 (382,782) 8,438
Preferred dividends 34,759 - 69,477 -
Net (loss) earnings
available to common
shareholders $(8,366) $79,727 $(452,259) $8,438
(Loss) earnings per
common share:
Basic $(0.03) $0.32 $(1.49) $0.04
Diluted $(0.03) $0.32 $(1.49) $0.03
Weighted average common
shares outstanding:
Basic 304,284 248,477 304,233 237,818
Diluted 304,284 251,604 304,233 241,129
Mylan Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(unaudited; in thousands)
June 30, 2008 December 31, 2007
Assets:
Current assets:
Cash and cash equivalents $478,508 $484,202
Restricted cash 40,000 -
Available for sale securities 53,476 91,361
Accounts receivable, net 1,318,177 1,132,121
Inventories 1,150,605 1,063,840
Other current assets 434,391 287,777
Total current assets
'/>"/>
| SOURCE Mylan Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Mylan Announces Final FDA Approval for Carvedilol Tablets
3. Mylan Announces Tentative FDA Approval for Topiramate Capsules
4. Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
5. Mylan Announces Extension of Tender Offers for Its 5.750% Senior Notes due 2010 and 6.375% Senior Notes due 2015
6. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
7. Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
8. Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
9. Mylan Announces Appointment of Harry A. Korman as President, North America
10. Mylan Announces Appointment of John Montgomery as President, Asia Pacific
11. Mylan Announces Management of Specialty Business, Dey L.P.
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |